Skip to Main Content

Paper Details

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA).
ESMO Open
0
2023
Author NameAffiliation
Alberto ZambelliPapa Giovanni XXIII Cancer Center Hospital
  • 1 - 1

Datasets

Release 1.2